Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LumenVu is a medical device company focused on improving the safety and accuracy of bedside catheter and tube placements. The company's core technology is an optical guidance system that utilizes near-infrared (NIR) light to provide real-time visualization of a catheter's tip through skin and tissue. Its flagship product, the LumenVu Enteral Access System, is designed to assist clinicians in the correct placement of nasogastric and nasojejunal feeding tubes without the need for ionizing radiation. By providing immediate visual confirmation of the tube's path and final position, the system aims to reduce the risk of lung misplacement and other serious complications. Spun out of the University of Utah, LumenVu addresses a critical need for safer, more efficient enteral access in hospital and critical care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LumenVu.